CARE-FOR-RARE
LIVE

Serial Number

79115776

Owner

Prof. Dr. Dr. Christoph Klein

Attorney

PATRICIA A WALKER

Filing Date

Jan 5, 2012

Add to watchlist:

No watchlists yet
View on USPTO

CARE-FOR-RARE Trademark

Serial Number: 79115776 • Registration: 4366431

CARE-FOR-RARE is a trademark filed by Prof. Dr. Dr. Christoph Klein on January 5, 2012. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Prof. Dr. Dr. Christoph Klein (3 trademarks)

Elmauer Str. 2a

Entity Type: 01

Prof. Dr. jur. Andreas Staudacher (3 trademarks)

Berblingerstraße 31
Laupheim 88471 , DE

Entity Type: 01

Trademark Details

Filing Date

January 5, 2012

Registration Date

July 16, 2013

Published for Opposition

April 30, 2013

Goods & Services

Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and providing medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children

Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans

Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling

Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 11, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
May 11, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 25, 2024 APRE
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Nov 6, 2023 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 16, 2023 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 18, 2023 ADCH
TEAS SECTION 71 RECEIVED
Jul 14, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2022 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jul 16, 2022 REM4
INTERNATIONAL REGISTRATION RENEWED
Jan 20, 2022 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2020 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 9, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 9, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 7, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 21, 2019 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Dec 27, 2018 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 21, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 13, 2013 FICS
FINAL DISPOSITION PROCESSED
Dec 13, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 16, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jul 1, 2013 GPNX
PUBLISHED FOR OPPOSITION
Apr 30, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 10, 2013 OP2R
NOTICE OF PUBLICATION
Apr 10, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 25, 2013 PREV
ASSIGNED TO LIE
Mar 25, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2013 TROA
REFUSAL PROCESSED BY IB
Sep 15, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 24, 2012 RFCS
REFUSAL PROCESSED BY MPU
Aug 23, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 23, 2012 RFCR
NON-FINAL ACTION WRITTEN
Aug 22, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 21, 2012 MAFR
ASSIGNED TO EXAMINER
Aug 17, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 16, 2012 REPR